SCHEMBL19505568

SCHEMBL19505568

CCSc1nc2c(c(=O)n(CCCOPI)c(=O)n2C)n1Cc1ccc(Cl)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.67
▸ MAPT P10636 5/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ NPSR1 Q6W5P4 3/20 0.53
▸ HTT P42858 1/20 0.53
▸ MAPK1 P28482 1/20 0.51
▸ KCNH2 Q12809 1/20 0.49
▸ TRPC4 Q9UBN4 1/20 0.49
▸ TRPC5 Q9UL62 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ LMNA P02545 3/20 0.48
▸ BRAF P15056 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ PIK3CG P48736 1/20 0.48
▸ POLB P06746 1/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MAOA P21397 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505260 0.91 TSHR (0.53) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL21499679 0.88 ALDH1A1 (0.68) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL16076235 0.86 TSHR (0.78) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL19505419 0.85 TRPC4 (0.49) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL19505592 0.85 TRPC4 (0.49) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL19505353 0.82 TRPC5 (0.58) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL18833941 0.82 TRPC4 (0.47) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL19505245 0.82 TRPC5 (0.57) TSHRMAPTALDH1A1NPSR1HTT
SCHEMBL21499673 0.81 SMN1; SMN2 (0.54) TSHRMAPTALDH1A1HTTMAPK1
SCHEMBL16028120 0.80 TSHR (0.59) TSHRMAPTALDH1A1NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed
US-10399982-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2019-09-03 — — US disclosed
US-9969736-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2018-05-15 — — US disclosed
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TSHR 4540/4885MAPT 2951/4885ALDH1A1 1647/4885
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof TRPC5, TRPC7, TRPC4 TSHR 4540/4885MAPT 2951/4885ALDH1A1 1647/4885
US-10399982-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 TSHR 4540/4885MAPT 2951/4885ALDH1A1 1647/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 TSHR 4540/4885MAPT 2951/4885ALDH1A1 1647/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TSHR 4540/4885MAPT 2951/4885ALDH1A1 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback